Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.290
-0.210 (-6.00%)
Aug 15, 2025, 3:20 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 88.37 million as of August 15, 2025. Its market cap has decreased by -66.51% in one year.
Market Cap
88.37M
Enterprise Value
106.80M
Revenue
44.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.29
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 88.37M, a decrease of -86.78%. That is a compound annual growth rate of -36.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 88.37M | 90.34% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.11B |
| Nordhealth AS | 2.93B |
| Photocure ASA | 1.64B |
| Vistin Pharma ASA | 1.06B |
| Omda AS | 1.02B |
| ArcticZymes Technologies ASA | 980.57M |
| Gentian Diagnostics ASA | 894.50M |
| Thor Medical ASA | 845.40M |